...
首页> 外文期刊>Parasitology Research >Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.
【24h】

Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi.

机译:人淋巴丝虫寄生虫马来亚布鲁加肌球蛋白的分子克隆,纯化和鉴定。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Global efforts have been made towards development of vaccine for prevention of lymphatic filariasis. However, lack of thorough knowledge about developmental biology and pathogenesis of filarial parasite restricts us from developing an effective vaccine. A limited number of immunodominant antigens of human lymphatic filariid Brugia malayi have been characterised; however, none of these recombinant antigens so far induced significant degree of protective immunity to challenge infection. In the present study, we identified a ~2.0 Kb cDNA clone by immunoscreening of cDNA library of adult female Brugia malayi. The nucleotide sequence of the identified clone showed 94.3% homology with C-terminal part of myosin heavy chain gene of Brugia malayi. This cDNA insert was sub-cloned into pET28b vector and expressed in BL21(DE3). The recombinant protein was purified to near homogeneity by immobilised metal affinity chromatography (IMAC) with yield of ~25 mg/l. The purified protein was recognised in western blot withanti-His tag antibody as also with the antibodies present in the sera of human W. bancrofti patients of all categories and infected/immunized rodent serum demonstrating its functional role. Recombinant myosin induced marked cellular immune response as observed by lymphoproliferation assay. The present findings demonstrate the usefulness of B. malayi recombinant myosin as vaccine candidate against human lymphatic filariasis.
机译:在开发用于预防淋巴丝虫病的疫苗方面已经做出了全球努力。但是,关于丝状寄生虫的发育生物学和发病机理缺乏透彻的知识,使我们无法开发出有效的疫苗。已经鉴定出有限数量的人类淋巴丝状马来氏布鲁氏菌的免疫显性抗原。然而,到目前为止,这些重组抗原均未诱导出显着程度的针对感染的保护性免疫。在本研究中,我们通过免疫筛选成年雌性马来亚布鲁吉(Brugia malayi)cDNA文库,鉴定了〜2.0 Kb cDNA克隆。鉴定出的克隆的核苷酸序列与马来西亚布鲁氏菌肌球蛋白重链基因的C末端部分具有94.3%的同源性。将该cDNA插入物亚克隆到pET28b载体中,并在BL21(DE3)中表达。重组蛋白通过固定金属亲和色谱法(IMAC)纯化至接近均一,产率约25 mg / l。用抗His标签抗体在蛋白质印迹中识别出纯化的蛋白质,并且在所有种类的班氏人W. bancrofti患者的血清中也存在抗体,并且被感染/免疫的啮齿动物血清证明了其功能。重组肌球蛋白诱导明显的细胞免疫反应,如淋巴增殖试验所观察到的。本发现表明,马来芽孢杆菌重组肌球蛋白可用作抗人淋巴丝虫病的候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号